This presentation is prepared by “ Drug Regulations” a
non profit organization which provides free online
resource to the Pharmaceutical Professional.
Visit http://www.drugregulations.org for latest
information from the world of Pharmaceuticals.
5/14/2015 1
 This presentation will cover all
aspects of GDP as per the proposal in
the
◦ Proposed USP–NF General Chapter
<1029>.
5/14/2015 2
Drug Regulations - Online Resource latest information.
 Documentation
◦ Foundation of all quality systems
◦ Clear, complete, accurate records
essential to all operations and
procedures.
5/14/2015 3
Drug Regulations - Online Resource latest information.
 Essential element in regulated manufacturing
and laboratory environments.
 Close adherence to GDP is required for an
auditable account of work performed.
 Required for all documentation included in a
fully developed quality system.
5/14/2015 4
Drug Regulations - Online Resource latest information.
 General Chapter Provides guidelines on how
to develop and maintain good
documentation practices .
 Address a need for descriptions of what
constitutes good documentation
◦ Records of all types that are clear, accurate, and complete.
5/14/2015 5
Drug Regulations - Online Resource latest information.
 General chapter provides guidelines to be used in the
production and control of
◦ Pharmaceutical products
◦ Active pharmaceutical ingredients (APIs)
◦ Excipients
◦ Dietary supplements
◦ Food ingredients
◦ Medical devices.
5/14/2015 6
Drug Regulations - Online Resource latest information.
 General chapter describes the underlying principles of
proper documentation for GMP operations
 Assists the user in the evaluation and reconstruction of
GMP activities.
 Guidelines will
◦ Help building basic foundation of a quality system
◦ Ensure proper documentation as well as record integrity and
control.
5/14/2015 7
Drug Regulations - Online Resource latest information.
 This chapter covers
◦ Different levels and types of documentation
◦ Paper and electronic records : raw data, reports, protocols,
and procedures related to manufacturing controls and
analytical data.
◦ Recommendations on information that should be recorded
for various types of GMP documents.
5/14/2015 8
Drug Regulations - Online Resource latest information.
 PRINCIPLES OF GOOD DOCUMENTATION
◦ Document all steps
◦ Manufacturing, testing, packaging, or holding
◦ Raw material, component, API, finished product
◦ Other similar items
5/14/2015 9
Drug Regulations - Online Resource latest information.
 PRINCIPLES OF GOOD DOCUMENTATION Manual or
electronic records include the following, as applicable:
◦ Records should be clear, concise, accurate, and legible.
◦ Data entries should be recorded promptly when actions are
performed.
◦ Backdating and postdating are prohibited.
◦ Initial & Date All corrections with an explanation included in
cases where the reason for the change is not obvious.
5/14/2015 10
Drug Regulations - Online Resource latest information.
 PRINCIPLES OF GOOD DOCUMENTATION Manual or electronic records include the
following, as applicable:
◦ Data entries should be traceable to the person who made the
entry.
◦ Do not use of shorthand notations.
◦ Place controls to protect the integrity of the records.
◦ In case of thermal paper use a copy with verification of its
accuracy;
 Analyst should initial and date the copy.
5/14/2015 11
Drug Regulations - Online Resource latest information.
 PRINCIPLES OF GOOD DOCUMENTATION Manual or electronic records
include the following, as applicable:
◦ An adequate documentation system required for
traceability and availability of records.
◦ Pre number notebooks, data sheets, and worksheets
◦ Retain records as per regulatory requirements.
◦ Paginate attachments (supporting documents) with a
reference to the parent document.
5/14/2015 12
Drug Regulations - Online Resource latest information.
 DATA COLLECTION AND RECORDING
◦ Formats for data collection and recording include:
◦ Paper forms, data sheets, and worksheets
◦ Notebooks and logbooks
◦ Instrument printouts
◦ Electronic data obtained with a system such as
 Electronic data system,
 Laboratory information management system (LIMS),
 Electronic laboratory notebook (ELN).
5/14/2015 13
Drug Regulations - Online Resource latest information.
 DATA COLLECTION AND RECORDING
◦ Record all data directly and legibly in indelible ink when
the activity is performed.
◦ Do not use sticky notes and other transitory loose
papers .
◦ All data entries should be traceable to who made the
entry and when.
◦ Electronic records must meet the requirements of 21
CFR, Part 11.
5/14/2015 14
Drug Regulations - Online Resource latest information.
 DATA COLLECTION AND RECORDING
◦ Change to an entry
 Make in a way so that original entry is not obscured
 Give an explanation for the change when change is
not obvious.
 Changes should be traceable to who made the
change and when.
5/14/2015 15
Drug Regulations - Online Resource latest information.
 DATA COLLECTION AND RECORDING
◦ Use notebook pages and worksheets
consecutively
◦ Record information chronologically
◦ Give unique identity to GMP records using
version control
5/14/2015 16
Drug Regulations - Online Resource latest information.
 DATA COLLECTION AND RECORDING
◦ Complete all data entry fields.
◦ Draw a single line and/or “N/A” through
portion(s) of a page that are not used.
◦ If an electronic record provides traceability of
who filled each field and when, the field can be
left blank.
5/14/2015 17
Drug Regulations - Online Resource latest information.
 DATA COLLECTION AND RECORDING
◦ Decimals less than one should be preceded by a
zero.
◦ Follow rounding rules and guidelines on
significant figures described in USP–NF.
◦ Express all dates so that the day, month, and
year is clearly understood.
5/14/2015 18
Drug Regulations - Online Resource latest information.
 DATA COLLECTION AND RECORDING
◦ Review all documentation
◦ A confirmation by second person may be required
to confirm the accuracy, compliance, and
completeness.
◦ Maintain an official record of signature and initials
for each employee.
5/14/2015 19
Drug Regulations - Online Resource latest information.
 DATA COLLECTION AND RECORDING
◦ Controls should be in place for assigning signature
approval requirements and delegation of signature
authority, when needed.
◦ Initial & date instrument printouts and data sheets
 Should contain a unique, traceable reference or
 affix to a reference document.
5/14/2015 20
Drug Regulations - Online Resource latest information.
 DATA COLLECTION AND RECORDING
◦ Verified copies of raw data may be substituted for the
original
◦ Sign all multiple page documents on the first page with a
note indicating the total number of pages.
 The first page and all subsequent pages should have a unique,
traceable reference to the activity being performed, such as the
notebook reference, study number, or worksheet reference.
5/14/2015 21
Drug Regulations - Online Resource latest information.
 Laboratory Record
◦ Each record should be concise, clear, legible, and
accurate, and detail the following:
◦ Description of materials, such as reagents.
5/14/2015 22
Drug Regulations - Online Resource latest information.
 Laboratory Record
◦ This information typically includes
 Material name
 Manufacturer
 Lot number
 Titer or Concentration,
 Expiration date,
 Quality (if known),
 Areference to the lab notebook if prepared in the lab.
5/14/2015 23
Drug Regulations - Online Resource latest information.
 Laboratory Record
◦ Identification of equipment used.
 Equipment name, unique control number, and calibration
expiration date.
◦ Procedures used
◦ Measurements
◦ Formulae and calculations
◦ Results and conclusions
5/14/2015 24
Drug Regulations - Online Resource latest information.
 Equipment Related Documentation
◦ All Manufacturing , testing, packing, or holding equipment
used for raw material, component, API, finished product, or
other similar item
◦ Maintain and qualify for its intended use.
◦ Documentation related to equipment includes:
 Policies and procedures for operation and maintenance
 Maintenance logs
 Calibration or qualification records
 Instrument labeling
5/14/2015 25
Drug Regulations - Online Resource latest information.
 Investigations and Deviations
◦ Document all
 Aberrations
 Anomalies
 Exceptions, and
 Issues related to manufacturing, testing, packing, or holding of
 a raw material, component, API, finished product, or other similar
item should be documented.
5/14/2015 26
Drug Regulations - Online Resource latest information.
 Investigations and Deviations
◦ Evaluate & Investigate the deviation as appropriate.
◦ Justify planned and unplanned deviations
◦ Have procedures for documenting, evaluating, and
investigating such events.
5/14/2015 27
Drug Regulations - Online Resource latest information.
 Investigations and Deviations
◦ Documentation of the investigation should include the following:
 Description of the event
 Root cause investigation and trend analysis
 Responsibilities of people involved in the investigation or
deviations
 Corrective Action and Preventive Action (CAPA) with timelines
Review and approval
5/14/2015 28
Drug Regulations - Online Resource latest information.
 Batch Records
◦ Create a Master Batch Record (MBR) as a template for the
manufacture of a specific product.
◦ Base executed Batch Record on the MBR
5/14/2015 29
Drug Regulations - Online Resource latest information.
 Batch Records
◦ Document the steps and materials involved in the production of a
specific batch of
 Raw material
 Component
 API
 Finished product
 or other similar item.
5/14/2015 30
Drug Regulations - Online Resource latest information.
 Batch Records
◦ Following sections are included and should be approved
◦ Approval by appropriate representative from the
manufacturing site or packaging site:
5/14/2015 31
Drug Regulations - Online Resource latest information.
 Batch Records Should contain
◦ Header information (e.g., product name, batch number,
manufacturing site)
◦ Unit of operation (e.g., blending, coating, filling)
◦ Manufacturing process
◦ Target weights (raw materials)
◦ Conditions (time, temperature)
5/14/2015 32
Drug Regulations - Online Resource latest information.
 Batch Records Should contain
◦ Deviations and investigations
◦ In process sampling or testing
◦ Critical information, as applicable
◦ Sampling plan for release, stability, and retention Review and
approval with approval dates
5/14/2015 33
Drug Regulations - Online Resource latest information.
 Certificate of Analysis
◦ Purpose is to report analytical results for a specific batch of
 Raw material
 Component
 API
 Finished product
 Other similar item.
5/14/2015 34
Drug Regulations - Online Resource latest information.
 Certificate of Analysis
◦ COA should be approved by an appropriate
representative from the testing site & contain
 Vendor or supplier information
 Product information (name and strength)
 Results for the specific batch, with name of test,
acceptance criteria, and result for each test
5/14/2015 35
Drug Regulations - Online Resource latest information.
 Certificate of Analysis
◦ COA should be approved by an appropriate
representative from the testing site & contain
 Conformance statement
 Reference to method and specification document
 Reference of data source
 Approval and date
 Expiration date or retest information
5/14/2015 36
Drug Regulations - Online Resource latest information.
 Standard Operating Procedures
◦ SOP’s provide directions to trained personnel regarding a given
set of activities.
◦ SOPs should be clear and concise.
◦ The following sections are typically included in an SOP:
 Purpose and scope
 Instructions and procedure
5/14/2015 37
Drug Regulations - Online Resource latest information.
 Standard Operating Procedures
◦ The following sections are typically included in an SOP:
 Responsibilities and roles
 Materials or equipment, as appropriate
 Definitions or references, as needed
 Review and approval
 Revision history
5/14/2015 38
Drug Regulations - Online Resource latest information.
 Protocols & Reports
◦ Many tasks and activities in the laboratory are executed on
the basis of a predefined, preapproved protocol.
◦ The results of these activities are then documented in a
final report with conclusions.
5/14/2015 39
Drug Regulations - Online Resource latest information.
 Protocols & Reports
◦ Examples of such activities are as follows:
 Equipment qualification
 Analytical method validation or verification
 Manufacturing process validation
 Analytical method or manufacturing technology transfer
 Cleaning validation
 Stability study or testing
 Comparability study
5/14/2015 40
Drug Regulations - Online Resource latest information.
 Protocols & Reports
◦ Both the protocol and the report should typically include
the following sections:
 Purpose
 Plan or instructions
 Predetermined acceptance criteria
 Deviations or investigations, including impact assessment
5/14/2015 41
Drug Regulations - Online Resource latest information.
 Protocols & Reports
◦ Both the protocol and the report should typically include
the following sections:
 Assessment or evaluation
 Data reference
 Review and approval
 Revision history
5/14/2015 42
Drug Regulations - Online Resource latest information.
 Analytical Methods
 Provides direction on how to perform a given analytical test.
Following sections will typically be included in the analytical
method:
◦ Purpose
◦ Test information
◦ Product information Safety information
◦ Materials and equipment
◦ Procedure, as applicable
◦ System suitability
5/14/2015 43
Drug Regulations - Online Resource latest information.
 Analytical Methods
 Provides direction on how to perform a given analytical test.
Following sections will typically be included in the analytical
method:
◦ Preparation of solutions and reagents
◦ Preparation of standards and samples
◦ Instrument parameters
◦ Calculations and reporting Review and approval with approval dates
◦ Revision history
5/14/2015 44
Drug Regulations - Online Resource latest information.
 Training Documentation
◦ Personnel should be trained to perform their assigned tasks.
◦ The training should be documented, and the training records
should be retained and kept readily accessible.
◦ Training records should be reviewed on a periodic basis for
accuracy and completeness.
5/14/2015 45
Drug Regulations - Online Resource latest information.
 Training Documentation
 In general, training documentation should include:
◦ Training description
◦ Name of training
◦ Version
◦ Mode (self training or instructor led)
◦ Completion date
◦ Information on the trainer’s qualifications
5/14/2015 46
Drug Regulations - Online Resource latest information.
 Retention of Documents
◦ Establish an adequate policy for record retention and
archiving
◦ Retention time depends on the regulatory requirements
◦ However, it should be at least 1 year after the batch
expiration date
5/14/2015 47
Drug Regulations - Online Resource latest information.
This presentation is prepared by “ Drug Regulations” a
non profit organization which provides free online
resource to the Pharmaceutical Professional.
Visit http://www.drugregulations.org for latest
information from the world of Pharmaceuticals.
5/14/2015 48

Good Documentation Practices

  • 1.
    This presentation isprepared by “ Drug Regulations” a non profit organization which provides free online resource to the Pharmaceutical Professional. Visit http://www.drugregulations.org for latest information from the world of Pharmaceuticals. 5/14/2015 1
  • 2.
     This presentationwill cover all aspects of GDP as per the proposal in the ◦ Proposed USP–NF General Chapter <1029>. 5/14/2015 2 Drug Regulations - Online Resource latest information.
  • 3.
     Documentation ◦ Foundationof all quality systems ◦ Clear, complete, accurate records essential to all operations and procedures. 5/14/2015 3 Drug Regulations - Online Resource latest information.
  • 4.
     Essential elementin regulated manufacturing and laboratory environments.  Close adherence to GDP is required for an auditable account of work performed.  Required for all documentation included in a fully developed quality system. 5/14/2015 4 Drug Regulations - Online Resource latest information.
  • 5.
     General ChapterProvides guidelines on how to develop and maintain good documentation practices .  Address a need for descriptions of what constitutes good documentation ◦ Records of all types that are clear, accurate, and complete. 5/14/2015 5 Drug Regulations - Online Resource latest information.
  • 6.
     General chapterprovides guidelines to be used in the production and control of ◦ Pharmaceutical products ◦ Active pharmaceutical ingredients (APIs) ◦ Excipients ◦ Dietary supplements ◦ Food ingredients ◦ Medical devices. 5/14/2015 6 Drug Regulations - Online Resource latest information.
  • 7.
     General chapterdescribes the underlying principles of proper documentation for GMP operations  Assists the user in the evaluation and reconstruction of GMP activities.  Guidelines will ◦ Help building basic foundation of a quality system ◦ Ensure proper documentation as well as record integrity and control. 5/14/2015 7 Drug Regulations - Online Resource latest information.
  • 8.
     This chaptercovers ◦ Different levels and types of documentation ◦ Paper and electronic records : raw data, reports, protocols, and procedures related to manufacturing controls and analytical data. ◦ Recommendations on information that should be recorded for various types of GMP documents. 5/14/2015 8 Drug Regulations - Online Resource latest information.
  • 9.
     PRINCIPLES OFGOOD DOCUMENTATION ◦ Document all steps ◦ Manufacturing, testing, packaging, or holding ◦ Raw material, component, API, finished product ◦ Other similar items 5/14/2015 9 Drug Regulations - Online Resource latest information.
  • 10.
     PRINCIPLES OFGOOD DOCUMENTATION Manual or electronic records include the following, as applicable: ◦ Records should be clear, concise, accurate, and legible. ◦ Data entries should be recorded promptly when actions are performed. ◦ Backdating and postdating are prohibited. ◦ Initial & Date All corrections with an explanation included in cases where the reason for the change is not obvious. 5/14/2015 10 Drug Regulations - Online Resource latest information.
  • 11.
     PRINCIPLES OFGOOD DOCUMENTATION Manual or electronic records include the following, as applicable: ◦ Data entries should be traceable to the person who made the entry. ◦ Do not use of shorthand notations. ◦ Place controls to protect the integrity of the records. ◦ In case of thermal paper use a copy with verification of its accuracy;  Analyst should initial and date the copy. 5/14/2015 11 Drug Regulations - Online Resource latest information.
  • 12.
     PRINCIPLES OFGOOD DOCUMENTATION Manual or electronic records include the following, as applicable: ◦ An adequate documentation system required for traceability and availability of records. ◦ Pre number notebooks, data sheets, and worksheets ◦ Retain records as per regulatory requirements. ◦ Paginate attachments (supporting documents) with a reference to the parent document. 5/14/2015 12 Drug Regulations - Online Resource latest information.
  • 13.
     DATA COLLECTIONAND RECORDING ◦ Formats for data collection and recording include: ◦ Paper forms, data sheets, and worksheets ◦ Notebooks and logbooks ◦ Instrument printouts ◦ Electronic data obtained with a system such as  Electronic data system,  Laboratory information management system (LIMS),  Electronic laboratory notebook (ELN). 5/14/2015 13 Drug Regulations - Online Resource latest information.
  • 14.
     DATA COLLECTIONAND RECORDING ◦ Record all data directly and legibly in indelible ink when the activity is performed. ◦ Do not use sticky notes and other transitory loose papers . ◦ All data entries should be traceable to who made the entry and when. ◦ Electronic records must meet the requirements of 21 CFR, Part 11. 5/14/2015 14 Drug Regulations - Online Resource latest information.
  • 15.
     DATA COLLECTIONAND RECORDING ◦ Change to an entry  Make in a way so that original entry is not obscured  Give an explanation for the change when change is not obvious.  Changes should be traceable to who made the change and when. 5/14/2015 15 Drug Regulations - Online Resource latest information.
  • 16.
     DATA COLLECTIONAND RECORDING ◦ Use notebook pages and worksheets consecutively ◦ Record information chronologically ◦ Give unique identity to GMP records using version control 5/14/2015 16 Drug Regulations - Online Resource latest information.
  • 17.
     DATA COLLECTIONAND RECORDING ◦ Complete all data entry fields. ◦ Draw a single line and/or “N/A” through portion(s) of a page that are not used. ◦ If an electronic record provides traceability of who filled each field and when, the field can be left blank. 5/14/2015 17 Drug Regulations - Online Resource latest information.
  • 18.
     DATA COLLECTIONAND RECORDING ◦ Decimals less than one should be preceded by a zero. ◦ Follow rounding rules and guidelines on significant figures described in USP–NF. ◦ Express all dates so that the day, month, and year is clearly understood. 5/14/2015 18 Drug Regulations - Online Resource latest information.
  • 19.
     DATA COLLECTIONAND RECORDING ◦ Review all documentation ◦ A confirmation by second person may be required to confirm the accuracy, compliance, and completeness. ◦ Maintain an official record of signature and initials for each employee. 5/14/2015 19 Drug Regulations - Online Resource latest information.
  • 20.
     DATA COLLECTIONAND RECORDING ◦ Controls should be in place for assigning signature approval requirements and delegation of signature authority, when needed. ◦ Initial & date instrument printouts and data sheets  Should contain a unique, traceable reference or  affix to a reference document. 5/14/2015 20 Drug Regulations - Online Resource latest information.
  • 21.
     DATA COLLECTIONAND RECORDING ◦ Verified copies of raw data may be substituted for the original ◦ Sign all multiple page documents on the first page with a note indicating the total number of pages.  The first page and all subsequent pages should have a unique, traceable reference to the activity being performed, such as the notebook reference, study number, or worksheet reference. 5/14/2015 21 Drug Regulations - Online Resource latest information.
  • 22.
     Laboratory Record ◦Each record should be concise, clear, legible, and accurate, and detail the following: ◦ Description of materials, such as reagents. 5/14/2015 22 Drug Regulations - Online Resource latest information.
  • 23.
     Laboratory Record ◦This information typically includes  Material name  Manufacturer  Lot number  Titer or Concentration,  Expiration date,  Quality (if known),  Areference to the lab notebook if prepared in the lab. 5/14/2015 23 Drug Regulations - Online Resource latest information.
  • 24.
     Laboratory Record ◦Identification of equipment used.  Equipment name, unique control number, and calibration expiration date. ◦ Procedures used ◦ Measurements ◦ Formulae and calculations ◦ Results and conclusions 5/14/2015 24 Drug Regulations - Online Resource latest information.
  • 25.
     Equipment RelatedDocumentation ◦ All Manufacturing , testing, packing, or holding equipment used for raw material, component, API, finished product, or other similar item ◦ Maintain and qualify for its intended use. ◦ Documentation related to equipment includes:  Policies and procedures for operation and maintenance  Maintenance logs  Calibration or qualification records  Instrument labeling 5/14/2015 25 Drug Regulations - Online Resource latest information.
  • 26.
     Investigations andDeviations ◦ Document all  Aberrations  Anomalies  Exceptions, and  Issues related to manufacturing, testing, packing, or holding of  a raw material, component, API, finished product, or other similar item should be documented. 5/14/2015 26 Drug Regulations - Online Resource latest information.
  • 27.
     Investigations andDeviations ◦ Evaluate & Investigate the deviation as appropriate. ◦ Justify planned and unplanned deviations ◦ Have procedures for documenting, evaluating, and investigating such events. 5/14/2015 27 Drug Regulations - Online Resource latest information.
  • 28.
     Investigations andDeviations ◦ Documentation of the investigation should include the following:  Description of the event  Root cause investigation and trend analysis  Responsibilities of people involved in the investigation or deviations  Corrective Action and Preventive Action (CAPA) with timelines Review and approval 5/14/2015 28 Drug Regulations - Online Resource latest information.
  • 29.
     Batch Records ◦Create a Master Batch Record (MBR) as a template for the manufacture of a specific product. ◦ Base executed Batch Record on the MBR 5/14/2015 29 Drug Regulations - Online Resource latest information.
  • 30.
     Batch Records ◦Document the steps and materials involved in the production of a specific batch of  Raw material  Component  API  Finished product  or other similar item. 5/14/2015 30 Drug Regulations - Online Resource latest information.
  • 31.
     Batch Records ◦Following sections are included and should be approved ◦ Approval by appropriate representative from the manufacturing site or packaging site: 5/14/2015 31 Drug Regulations - Online Resource latest information.
  • 32.
     Batch RecordsShould contain ◦ Header information (e.g., product name, batch number, manufacturing site) ◦ Unit of operation (e.g., blending, coating, filling) ◦ Manufacturing process ◦ Target weights (raw materials) ◦ Conditions (time, temperature) 5/14/2015 32 Drug Regulations - Online Resource latest information.
  • 33.
     Batch RecordsShould contain ◦ Deviations and investigations ◦ In process sampling or testing ◦ Critical information, as applicable ◦ Sampling plan for release, stability, and retention Review and approval with approval dates 5/14/2015 33 Drug Regulations - Online Resource latest information.
  • 34.
     Certificate ofAnalysis ◦ Purpose is to report analytical results for a specific batch of  Raw material  Component  API  Finished product  Other similar item. 5/14/2015 34 Drug Regulations - Online Resource latest information.
  • 35.
     Certificate ofAnalysis ◦ COA should be approved by an appropriate representative from the testing site & contain  Vendor or supplier information  Product information (name and strength)  Results for the specific batch, with name of test, acceptance criteria, and result for each test 5/14/2015 35 Drug Regulations - Online Resource latest information.
  • 36.
     Certificate ofAnalysis ◦ COA should be approved by an appropriate representative from the testing site & contain  Conformance statement  Reference to method and specification document  Reference of data source  Approval and date  Expiration date or retest information 5/14/2015 36 Drug Regulations - Online Resource latest information.
  • 37.
     Standard OperatingProcedures ◦ SOP’s provide directions to trained personnel regarding a given set of activities. ◦ SOPs should be clear and concise. ◦ The following sections are typically included in an SOP:  Purpose and scope  Instructions and procedure 5/14/2015 37 Drug Regulations - Online Resource latest information.
  • 38.
     Standard OperatingProcedures ◦ The following sections are typically included in an SOP:  Responsibilities and roles  Materials or equipment, as appropriate  Definitions or references, as needed  Review and approval  Revision history 5/14/2015 38 Drug Regulations - Online Resource latest information.
  • 39.
     Protocols &Reports ◦ Many tasks and activities in the laboratory are executed on the basis of a predefined, preapproved protocol. ◦ The results of these activities are then documented in a final report with conclusions. 5/14/2015 39 Drug Regulations - Online Resource latest information.
  • 40.
     Protocols &Reports ◦ Examples of such activities are as follows:  Equipment qualification  Analytical method validation or verification  Manufacturing process validation  Analytical method or manufacturing technology transfer  Cleaning validation  Stability study or testing  Comparability study 5/14/2015 40 Drug Regulations - Online Resource latest information.
  • 41.
     Protocols &Reports ◦ Both the protocol and the report should typically include the following sections:  Purpose  Plan or instructions  Predetermined acceptance criteria  Deviations or investigations, including impact assessment 5/14/2015 41 Drug Regulations - Online Resource latest information.
  • 42.
     Protocols &Reports ◦ Both the protocol and the report should typically include the following sections:  Assessment or evaluation  Data reference  Review and approval  Revision history 5/14/2015 42 Drug Regulations - Online Resource latest information.
  • 43.
     Analytical Methods Provides direction on how to perform a given analytical test. Following sections will typically be included in the analytical method: ◦ Purpose ◦ Test information ◦ Product information Safety information ◦ Materials and equipment ◦ Procedure, as applicable ◦ System suitability 5/14/2015 43 Drug Regulations - Online Resource latest information.
  • 44.
     Analytical Methods Provides direction on how to perform a given analytical test. Following sections will typically be included in the analytical method: ◦ Preparation of solutions and reagents ◦ Preparation of standards and samples ◦ Instrument parameters ◦ Calculations and reporting Review and approval with approval dates ◦ Revision history 5/14/2015 44 Drug Regulations - Online Resource latest information.
  • 45.
     Training Documentation ◦Personnel should be trained to perform their assigned tasks. ◦ The training should be documented, and the training records should be retained and kept readily accessible. ◦ Training records should be reviewed on a periodic basis for accuracy and completeness. 5/14/2015 45 Drug Regulations - Online Resource latest information.
  • 46.
     Training Documentation In general, training documentation should include: ◦ Training description ◦ Name of training ◦ Version ◦ Mode (self training or instructor led) ◦ Completion date ◦ Information on the trainer’s qualifications 5/14/2015 46 Drug Regulations - Online Resource latest information.
  • 47.
     Retention ofDocuments ◦ Establish an adequate policy for record retention and archiving ◦ Retention time depends on the regulatory requirements ◦ However, it should be at least 1 year after the batch expiration date 5/14/2015 47 Drug Regulations - Online Resource latest information.
  • 48.
    This presentation isprepared by “ Drug Regulations” a non profit organization which provides free online resource to the Pharmaceutical Professional. Visit http://www.drugregulations.org for latest information from the world of Pharmaceuticals. 5/14/2015 48